Cleveland, OHNCT06046222Now EnrollingIRB Ready

Eosinophilic Granulomatosis With Polyangiitis Clinical Trial in Cleveland, OH

Access cutting-edge eosinophilic granulomatosis with polyangiitis treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by NS Pharma, Inc.

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions...

Expert Care in Cleveland

Access eosinophilic granulomatosis with polyangiitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related eosinophilic granulomatosis with polyangiitis treatment provided free

Apply for This Cleveland Location

Check if you qualify for this eosinophilic granulomatosis with polyangiitis clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Eosinophilic Granulomatosis With Polyangiitis Study in Cleveland

This study will enroll male and female subjects who are 18 years of age or older with Eosinophilic Granulomatosis With Polyangiitis.

Sponsor: NS Pharma, Inc.

Who Can Participate

Inclusion Criteria

Ability to provide written informed consent prior to participation in the study.
Male or female subjects aged ≥18 years at the time the informed consent form is signed.
Diagnosis of EGPA: Subjects who have been diagnosed with EGPA based on the history or presence of eosinophilia plus at least a history or presence of 2 of additional features of EGPA.
Subjects receive background OGC dose of ≥7.5 mg/day with or without stable treatment with Mepolizumab/Benralizumab.
Use of adequate contraception.
Other inclusion criteria may apply.

Exclusion Criteria

Current diagnosis of either granulomatosis with polyangiitis or microscopic polyangiitis
Imminently life-threatening EGPA at the time of screening.
History or presence of any form of cancer within 5 years prior to screening.
Serious liver, renal, blood, or psychiatric disease
Severe or clinically significant cardiovascular disease uncontrolled with standard treatment
Active systemic infections

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT06046222) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Eosinophilic Granulomatosis With Polyangiitis Treatment Options in Cleveland, OH

If you're searching for eosinophilic granulomatosis with polyangiitis treatment options in Cleveland, OH, this clinical trial (NCT06046222) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced eosinophilic granulomatosis with polyangiitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all eosinophilic granulomatosis with polyangiitis clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Cleveland, OH

See all rheumatoid arthritis clinical trials recruiting in Cleveland — not just this study.

Browse Rheumatoid Arthritis Trials in Cleveland →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsVasculitis TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH